leoss.sero-survey blog
Stay up to date with the latest News.
Second Interimsanalyse Immunebridge-Project
For all participating studies, we have the second analysis for modelling groups.
Results Immunebridge
For all participating studies, we have preliminary results for modelling groups
A new dashboard
After a long period of data cleaning processes and study aquisition, we are presenting the dashboard with selected KPI of the data included in the serohub.
How many people are now immune to SARS-CoV-2?
Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus?
District of Reutlingen is the first region chosen for serological testing in the population
Scientific data indicate that many COVID-19 cases are not recorded due to mild or asymptomatic infections.
EBI discusses Standardization of Reporting on Serology Data
The European Bioinformatics Institute (EBI) is engaged in discussion about standardization of reporting on serology data, in order to be able to integrate serolomics into the COVID-19 Data Portal
Overview of SARS-COV-2 studies seroprevalence in context of the worldwide COVID-19 pandemie. You can register a study here: Contribute
serohub@helmholtz-hzi.de
@serohub on Twitter
hzi-braunschweig/serohub on GitHub